MakeMyTrip Ltd vs Zimmer Biomet Holdings Inc — how do they compare? MakeMyTrip Ltd trades at $56.43 (market cap $5.05B), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 3.4× MakeMyTrip Ltd's market cap, and Zimmer Biomet Holdings Inc pays a 1.07% dividend while MakeMyTrip Ltd pays none. Which is the better fit depends on your goals.
| MMYT | ZBH | |
|---|---|---|
Market Cap | $5.05B | $17.36B |
Sector | Technology | Health |
52-Week High | $103.21 | $107.71 |
52-Week Low | $36.30 | $79.58 |
Enterprise Value | $5.69B | $24.40B |
Dividend Yield | — | 1.07% |
Trailing returns across standard periods
MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →